Smeeta Gajendra
Smeeta Gajendra publishes mostly in Hematology, Public Health, Environmental and Occupational Health and Genetics, on topics such as Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research and Chronic Myeloid Leukemia Treatments.
- World rank
- #7,654,210 of 7,710,434 ranked researchers
- Rank in India
- #278,224 of 280,097
- Works
- 108
- Citations
- 502
- Citations per work
- 4.6
What does Smeeta Gajendra research?
Smeeta Gajendra's work is mostly in Medicine (57%), Biochemistry, Genetics and Molecular Biology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences6257.0%
- Medicine6257.0%
- Everything else3734.2%
- Life Sciences108.8%
- 1Hematology27% of their works
- 2Public Health, Environmental and Occupational Health10% of their works
- 3Genetics9% of their works
- 4Molecular Biology9% of their works
- 5Epidemiology6% of their works
- 6Pathology and Forensic Medicine6% of their works
Research topics
- Acute Myeloid Leukemia Research
- Acute Lymphoblastic Leukemia research
- Chronic Myeloid Leukemia Treatments
- Chronic Lymphocytic Leukemia Research
- Lymphoma Diagnosis and Treatment
- Multiple Myeloma Research and Treatments
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hematological disorders and diagnostics
Which keywords describe Smeeta Gajendra's research?
The keywords of their largest research topics: Prognostic Factors, Acute Myeloid Leukemia, AML, Minimal Residual Disease, Rituximab, Acute Lymphoblastic Leukemia, Childhood Cancer and BCR-ABL.
- Bone Marrow Biopsy
- JAK2 Mutation
- Diagnosis Criteria
- Classification
- Chronic Lymphocytic Leukemia
- BCR-ABL
- Acute Lymphoblastic Leukemia
- Minimal Residual Disease
- AML
- Prognostic Factors
- Acute Myeloid Leukemia
- Rituximab
- Childhood Cancer
- Imatinib
- Genomic Aberrations
- Lymphoma
- International Myeloma Working Group
- Myelofibrosis
- FDG PET/CT
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Prognostic Factors883 topics
- AML431 topic
- Acute Myeloid Leukemia431 topic
- Minimal Residual Disease402 topics
- Rituximab302 topics
- Acute Lymphoblastic Leukemia291 topic
- Childhood Cancer291 topic
- BCR-ABL211 topic
- Imatinib211 topic
- Chronic Lymphocytic Leukemia161 topic
- Genomic Aberrations161 topic
- Classification141 topic
- Lymphoma141 topic
- Diagnosis Criteria111 topic
- International Myeloma Working Group111 topic
- JAK2 Mutation101 topic
- Myelofibrosis101 topic
- Bone Marrow Biopsy71 topic
- FDG PET/CT71 topic
Where does Smeeta Gajendra work?
Smeeta Gajendra's main affiliation in the publication record is All India Institute of Medical Sciences, India.
How many publications and citations does Smeeta Gajendra have?
OpenAlex counts 108 works and 502 citations for Smeeta Gajendra, an h-index of 14, ranking #7,654,210 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Smeeta Gajendra. Posts are plain text and can be reported.